No Data
No Data
ScPharmaceuticals' Earnings Call Highlights Growth and Challenges
A Quick Look at Today's Ratings for ScPharmaceuticals(SCPH.US), With a Forecast Between $11 to $25
Analyst Expectations For ScPharmaceuticals's Future
Maxim Group Maintains Buy on ScPharmaceuticals, Lowers Price Target to $12
Q4 2024 ScPharmaceuticals Inc Earnings Call
Craig-Hallum Sticks to Its Buy Rating for ScPharmaceuticals (SCPH)
Trytosaveabit OP : Second bullet points is crazy increase! Hehehe
LeadByAnimals : Good numbers!! They beat the estimate so hopefully some positive market sentiment comes in the near future!! I would be very happy if the analysts were proven right on their projections for this one!! lol